LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

LLY

1,030.68

+0.87%↑

JNJ

200.1

+0.41%↑

ABBV

233.97

+0.04%↑

UNH

313.81

-2.05%↓

AZN

89.31

+0.18%↑

Strona główna・Stock List・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Closed

SectorHealthcare

33.96 0.15

Buy Sell

Overview

Share price change

24h

Current

Min

33.32

Max

34.1

Key metrics
By Trading Economics
Income	11M 51M
Sales	39M 239M
P/E Sector Avg	10.038 105.69
EPS	1.08
Profit margin	21.242
Employees	268
EBITDA	12M 71M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+35.33% upside

Market Stats
By TradingEconomics
Market Cap	145M 1.8B
Previous open	33.81
Previous close	33.96

News Sentiment

By Acuity

34%

66%

104 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

29.8 / N/A Support & Resistance

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

18 lis 2025, 19:25 UTC

Acquisitions, Mergers, Takeovers

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- 2nd Update

18 lis 2025, 18:09 UTC

Acquisitions, Mergers, Takeovers

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- Update

18 lis 2025, 17:39 UTC

Acquisitions, Mergers, Takeovers

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough

18 lis 2025, 16:25 UTC

Major Market Movers

Diginex Rises on Deal With Digital Asset Platform Evident

18 lis 2025, 23:56 UTC

Market Talk

Gold Edges Higher on Likely Technical Recovery -- Market Talk

18 lis 2025, 23:39 UTC

Market Talk

Nikkei May Rise on Bargain-Hunting Interest -- Market Talk

18 lis 2025, 22:59 UTC

Market Talk

FireFly Metals Can Build Bigger Operation at Green Bay -- Market Talk

18 lis 2025, 22:08 UTC

Market Talk

Sandfire's Kalkaroo Project Push Adds to Copper M&A Surge -- Market Talk

18 lis 2025, 22:03 UTC

Acquisitions, Mergers, Takeovers

Meta Defeats FTC's Antitrust Case Alleging Social-Media Monopoly -- 3rd Update

18 lis 2025, 22:03 UTC

Earnings

These Stocks Moved the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18 lis 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

18 lis 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18 lis 2025, 21:15 UTC

Market Talk

Private High-Grade Credit Market Is Changing, BlackRock Says -- Market Talk

18 lis 2025, 20:46 UTC

Market Talk

U.S. Natural Gas Futures Edge Up on Weather Outlook -- Market Talk

18 lis 2025, 20:13 UTC

Market Talk

Distillate Supply Concerns Pull Crude Futures Higher -- Market Talk

18 lis 2025, 19:48 UTC

Market Talk

Gold and Silver Turn Lower on Fed Outlook -- Market Talk

18 lis 2025, 19:19 UTC

Acquisitions, Mergers, Takeovers

Anheuser-Busch InBev Nears $700 Million Deal for Party Punch Maker BeatBox -- WSJ

18 lis 2025, 19:19 UTC

Acquisitions, Mergers, Takeovers

Anheuser-Busch InBev in Talks to Buy Party Punch Maker BeatBox, Sources Say -- WSJ

18 lis 2025, 19:19 UTC

Acquisitions, Mergers, Takeovers

AB InBev-BeatBox Deal Could Come Together Soon, Sources Say -- WSJ

18 lis 2025, 19:19 UTC

Acquisitions, Mergers, Takeovers

AB InBev Deal Would Value BeatBox At Around $700M, Sources Say -- WSJ

18 lis 2025, 18:29 UTC

Earnings

These Stocks Are Moving the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18 lis 2025, 18:18 UTC

Market Talk

Ethanol Demand Expected to Boost Corn Futures -- Market Talk

18 lis 2025, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18 lis 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

18 lis 2025, 17:19 UTC

Market Talk

Earnings

Good Weather Was Bad News for Home Depot's 3Q -- Market Talk

18 lis 2025, 17:06 UTC

Earnings

Medtronic Stock Rises After Earnings. What Caught Investors' Attention. -- Barrons.com

18 lis 2025, 16:06 UTC

Acquisitions, Mergers, Takeovers

Intuit Stock Gains on OpenAI Deal. ChatGPT Is Coming to TurboTax. -- Barrons.com

18 lis 2025, 15:59 UTC

Earnings

Home Depot Cuts Outlook as Home Improvement Slowdown Continues -- Update

18 lis 2025, 15:35 UTC

Acquisitions, Mergers, Takeovers

Eni: Acquisition Adds to Plenitude's Installed-Capacity Targets, Bolsters France Presence

18 lis 2025, 15:35 UTC

Acquisitions, Mergers, Takeovers

Eni: Portfolio Comprises Capacity of Around 760MW in Operation

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

35.33% upside

12 Months Forecast

Average 46 USD 35.33%

High 62 USD

Low 32 USD

Based on 10 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

Buy

Hold

Sell

Based on 10 analysts giving stock ratings to Harmony Biosciences Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

104 / 374 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.